Evidence map›Paper›PMID 41514076›Full record

ArticleEye (London, England)2026

Inherited retinal disorders in Scotland: A 5 year assessment.

James E Hazelwood, Mertcan Sevgi, Fiona Osborne, Blazej Staniszewski, Nick George, Andreea Ionean, David F Gilmour, Roly Megaw

Abstract read
In one paragraph

Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James E HazelwoodPrincess Alexandra Eye Pavilion, NHS Lothian, Chalmers St, Edinburgh, EH3 9HA, UK. jhazelwo@ed.ac.uk.ORCID 0000-0002-2794-4330
Mertcan SevgiGartnavel hospital, NHS Greater Glasgow & Clyde, Aberdeen, UK.
Fiona OsborneAberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
Blazej StaniszewskiNinewells hospital, NHS Tayside, Aberdeen, UK.
Nick GeorgeNinewells hospital, NHS Tayside, Aberdeen, UK.
Andreea IoneanAberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
David F GilmourGartnavel hospital, NHS Greater Glasgow & Clyde, Aberdeen, UK.
Roly MegawPrincess Alexandra Eye Pavilion, NHS Lothian, Chalmers St, Edinburgh, EH3 9HA, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveInherited Retinal Disorders (IRDs) are a leading cause of blindness in working age adults. With the emergence of therapeutic approaches and pre-implantation genetic testing, obtaining a molecular diagnosis is increasingly important. As such we aimed to determine the caseload of IRD patients presenting to Scottish ophthalmology services over a 5-year period, and evaluated the diagnostic approaches used and results of genetic testing in order to determine any established inherited cause. SUBJECTS: Data from all patients presenting to ophthalmology services across Scotland from January 2018 to January 2023 diagnosed with an IRD were collected. History and examination findings were recorded, as were the methods of genetic testing used, the identified genetic variants and the time taken for molecular reporting.

results532 patients were included in the analysis. The most common clinical diagnosis was retinitis pigmentosa (RP) (42.4%), followed by Stargardt Disease (9.0%), with Usher syndrome the most common syndromic RP. The most common initial test was a 176 gene panel, followed by direct testing for ABCA4, with different regions pursuing different testing strategies. 67.4% of patients received a molecular diagnosis. The most common causal gene was ABCA4, followed by USH2A and RDS/PRPH2.

conclusionThis study provides the first assessment of IRDs in Scotland over a 5 year period. We demonstrate that the most common clinical diagnoses are RP and Stargardt disease, and that the majority received a molecular diagnosis. This work provides a unique insight into the Scottish ophthalmic genetics service and serves as a benchmark for iterative improvement.

Indexed as

Retinal DiseasesAdolescentAdultAgedATP-Binding Cassette TransportersChildExtracellular Matrix ProteinsFemaleGenetic TestingHumansMaleMiddle AgedPeripherinsScotlandYoung AdultABCA4 protein, humanATP-Binding Cassette TransportersExtracellular Matrix ProteinsPeripherinsPRPH2 protein, humanUSH2A protein, human

Identifiers

PMID41514076
PMCPMC12957440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.